β-elemene suppressed EMT via IGF1R inhibition in osimertinib treated AXL low-expressing EGFR mutant non-small cell lung cancer

Biophysical Reports · Elsevier

Abstract

Publication date: 10 January 2027 Source: European Journal of Pharmacology, Volume 1040 Author(s): Jun-Hu Hu, Yan-bin Hu, Li-Hua Yu, Tian-Ge Xiang, Xiao-Guang Shang, William Chi-Shing Tai, Ling-Feng Dong, Yu-Wen Zhang, Zhi-Ling Yu, Tian Xie, Jian-Shu Lou

Read at publisher →

Similar articles